Sinopharm will be considered a Special Access Route vaccine and will not be subsidised by the Government
This Special Access Route framework allows private healthcare groups to fly in Covid-19 vaccines that the World Health Organisation (WHO) has listed for emergency use. Currently, this includes Sinovac, Sinopharm, Johnson & Johnson and Oxford-AstraZeneca.
Since Sinopharm does not fall under the Pandemic Special Access Route framework like Pfizer-BioNTech and Moderna, it will not be subsidised by the Government.
Individuals who choose to take Sinopharm will also not be covered under the Vaccine Injury Financial Assistance Programme, which is in place to help people who suffer from adverse effects from their Covid-19 vaccinations.
This forum is moderated by volunteer moderators who will react only to members' feedback on posts. Moderators are not employees or representatives of HWZ. Forum members and moderators are responsible for their own posts.
Please refer to our Terms of Service for more information.